chinese glp-1 Innovent's weight-loss drug highlights China challenge for Novo, Lilly As China's drug industry races

Upcoming Removal of Selected GLP-1 Drugs from Medi-Cal Rx Effective January 1, 2026, Californias Medi-Cal Rx program will remove certain medications from its contract drug list

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.

Choosing the right injection site for GLP-1 medications involves understanding anatomy, absorption patterns, and individual tolerance

VANCOUVER, WA / ACCESS Newswire / July 16, 2026 / LIR Life Sciences Corp

It comes in two main varieties: smoked and u...